BioSynchro in West AB
ActiveKey figures
Key figures
2025Summary: BioSynchro in West AB
What kind of company is it?
BioSynchro in West AB (org. no. 559072-4869) is a limited company (AB). The company was registered in 2016 and has existed for 10 years. Registered seat: Kungsbacka. Industry according to Statistics Sweden: business and other management consultancy activities (SNI 70200).
How is the company doing financially?
Net sales in financial year 2025 were 50 000 kr, up 11,1 % on the previous year (45 000 kr). Net profit for 2025 was 1 810 kr (3,6 % of net sales). The company was profitable in 6 of the 8 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 50 000 kr. At the end of financial year 2025, total assets were 315 650 kr and equity 272 065 kr (equity ratio 86,2 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 150 000 kr.
Summary of annual reports2018–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 268 000 | 210 000 | 255 000 | 45 000 | 50 000 |
| Profit for the reporting year | 210 366 | 159 010 | 186 484 | 24 024 | 1 810 |
| Retained earnings of previous periods | — | — | — | — | — |
| Total assets | 414 667 | 456 727 | 458 853 | 298 241 | 315 650 |
| Total liabilities | 153 931 | 246 980 | 212 622 | 27 986 | 43 585 |
| Total equity | 260 736 | 209 747 | 246 231 | 270 255 | 272 065 |
| Employees | — | — | — | 1 | 1 |
| Proposed dividend | 210 000 | 150 000 | — | — | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.